{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:45:52Z","timestamp":1789148752259,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["MH-57483"],"award-info":[{"award-number":["MH-57483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["MH-57483S"],"award-info":[{"award-number":["MH-57483S"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RR-20750"],"award-info":[{"award-number":["RR-20750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["MH-77248"],"award-info":[{"award-number":["MH-77248"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DA-22539"],"award-info":[{"award-number":["DA-22539"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Organon Research Laboratories, Ltd"},{"name":"Pfizer Central Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neuropharm.2011.08.026","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T20:35:37Z","timestamp":1314304537000},"page":"1442-1452","source":"Crossref","is-referenced-by-count":26,"title":["Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration"],"prefix":"10.1016","volume":"62","author":[{"given":"John D.","family":"Elsworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Groman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Jentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Valles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Marston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.08.026_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2006.01.019","article-title":"The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm","volume":"169","author":"Abdul-Monim","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","article-title":"Phencyclidine-induced psychosis","volume":"135","author":"Allen","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/sj.npp.1300394","article-title":"Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine","volume":"29","author":"Andersen","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib4","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1523\/JNEUROSCI.4682-05.2006","article-title":"Cortical and subcortical contributions to stop signal response inhibition: role of the subthalamic nucleus","volume":"26","author":"Aron","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tics.2004.02.010","article-title":"Inhibition and the right inferior frontal cortex","volume":"8","author":"Aron","year":"2004","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0893-133X(01)00230-5","article-title":"Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release","volume":"25","author":"Balla","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/brain\/awh135","article-title":"Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions","volume":"127","author":"Berlin","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2007.02.005","article-title":"Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat","volume":"179","author":"Boulougouris","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","article-title":"Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats","volume":"33","author":"Boulougouris","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib10","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1126\/science.1060818","article-title":"Impulsive choice induced in rats by lesions of the nucleus accumbens core","volume":"292","author":"Cardinal","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-003-1710-9","article-title":"Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia","volume":"174","author":"Castner","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib12","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1523\/JNEUROSCI.23-25-08771.2003","article-title":"Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex","volume":"23","author":"Chudasama","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1094987","article-title":"Cognitive inflexibility after prefrontal serotonin depletion","volume":"304","author":"Clarke","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1523\/JNEUROSCI.3690-04.2005","article-title":"Prefrontal serotonin depletion affects reversal learning but not attentional set shifting","volume":"25","author":"Clarke","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cercor\/bhj120","article-title":"Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific","volume":"17","author":"Clarke","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02246578","article-title":"The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type","volume":"123","author":"Coull","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/schbul\/23.1.63","article-title":"Perseveration in schizophrenia","volume":"23","author":"Crider","year":"1997","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbr.2005.08.013","article-title":"Rule shift under long-term PCP challenge in rats","volume":"167","author":"Deschenes","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/syn.10264","article-title":"Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex","volume":"50","author":"Devoto","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/380069a0","article-title":"Dissociation in prefrontal cortex of affective and attentional shifts","volume":"380","author":"Dias","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0306-4522(89)90212-1","article-title":"Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions","volume":"33","author":"Elsworth","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0963-6897(95)02034-9","article-title":"Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys","volume":"5","author":"Elsworth","year":"1996","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib23","series-title":"Sycrest (Asenapine)","year":"2010"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/brain\/awg180","article-title":"Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm","volume":"126","author":"Fellows","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00213-005-0157-6","article-title":"Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex","volume":"183","author":"Fletcher","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/schbul\/sbi041","article-title":"Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia","volume":"31","author":"Floresco","year":"2005","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-008-1456-5","article-title":"Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms","volume":"204","author":"Franberg","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/0033-295X.113.2.300","article-title":"Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal","volume":"113","author":"Frank","year":"2006","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0006-3223(00)01027-1","article-title":"Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications","volume":"49","author":"Green","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1471-4159.1995.65010111.x","article-title":"Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex","volume":"65","author":"Gresch","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(99)00041-5","article-title":"A\u00a0double-blind study comparing idazoxan and bupropion in bipolar depressed patients","volume":"56","author":"Grossman","year":"1999","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/schbul\/sbi058","article-title":"Predicting drug efficacy for cognitive deficits in schizophrenia","volume":"31","author":"Hagan","year":"2005","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.npp.1301047","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors","volume":"32","author":"Hashimoto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.286.5437.105","article-title":"Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade","volume":"286","author":"Hertel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(99)00175-2","article-title":"Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level","volume":"371","author":"Hertel","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF00237911","article-title":"Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity","volume":"11","author":"Iversen","year":"1970","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0893-133X(00)00174-3","article-title":"Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats","volume":"24","author":"Jentsch","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib40","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1523\/JNEUROSCI.17-05-01769.1997","article-title":"Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966","volume":"17","author":"Jentsch","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib41","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.277.5328.953","article-title":"Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine","volume":"277","author":"Jentsch","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(97)00034-1","article-title":"Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat","volume":"17","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib43","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1054-3589(08)60870-4","article-title":"Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia","volume":"42","author":"Jentsch","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<21::AID-SYN3>3.0.CO;2-E","article-title":"Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex","volume":"28","author":"Jentsch","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0306-4522(98)00481-3","article-title":"Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits","volume":"90","author":"Jentsch","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0006-3223(00)00926-4","article-title":"Object retrieval\/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity","volume":"48","author":"Jentsch","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0893-133X(01)00355-4","article-title":"Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys","volume":"26","author":"Jentsch","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.10.006","article-title":"Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype","volume":"1246","author":"Jentsch","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cnr.2003.10.011","article-title":"Pre-clinical models of cognitive dysfunction in schizophrenia: new avenues to addressing unmet needs","volume":"3","author":"Jentsch","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/7854_2010_42","article-title":"Neurocognition in schizophrenia","volume":"4","author":"Kalkstein","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib51","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF03000221","article-title":"Transference, discrimination and reversal. A comparison between normals and pathological groups","volume":"7","author":"Klingner","year":"1972","journal-title":"Cond Reflex"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0920-9964(94)90056-6","article-title":"Error-correcting behavior in schizophrenic patients","volume":"13","author":"Kopp","year":"1994","journal-title":"Schizophr Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/14622416.6.2.139","article-title":"Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics","volume":"6","author":"Lane","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00008877-200403000-00006","article-title":"Subchronic phencyclidine treatment impairs performance of C57BL\/6 mice in the attentional set-shifting task","volume":"15","author":"Laurent","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib56","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/sj.npp.1301337","article-title":"Dopamine D2\/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys","volume":"32","author":"Lee","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Schizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1192\/bjp.168.5.571","article-title":"Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine","volume":"168","author":"Litman","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib59","article-title":"Transcranial magnetic stimulation reveals dissociable mechanisms for global versus selective corticomotor suppression underlying the stopping of action","author":"Majid","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib62","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S1461145709990794","article-title":"Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission","volume":"13","author":"Marcus","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1074-7427(03)00067-4","article-title":"Schizophrenia-like syndrome inducing agent phencyclidine failed to impair memory for temporal order in rats","volume":"80","author":"Marquis","year":"2003","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00213-006-0559-0","article-title":"Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go\/no-go task in rats","volume":"189","author":"Masaki","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","article-title":"In\u00a0vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems","volume":"172","author":"Meltzer","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib66","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Suppl. 99","key":"10.1016\/j.neuropharm.2011.08.026_bib67","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib68","series-title":"Saphris\u00ae","year":"2010"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0893-133X(00)00138-X","article-title":"Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions","volume":"23","author":"Noda","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0166-4328(97)02304-8","article-title":"Stimulus dimension shifts in patients with schizophrenia, with and without paranoid hallucinatory symptoms, or obsessive compulsive disorder: strategies, blocking and monoamine status","volume":"88","author":"Oades","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib72","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.v68n1004","article-title":"Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial","volume":"68","author":"Potkin","year":"2007","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib73","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1176\/ajp.132.10.1076","article-title":"Prolonged psychosis attributed to phencyclidine: report of three cases","volume":"132","author":"Rainey","year":"1975","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib74","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.euroneuro.2004.07.001","article-title":"Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response","volume":"15","author":"Reynolds","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.08.026_bib75","doi-asserted-by":"crossref","first-page":"i151","DOI":"10.1093\/cercor\/bhm066","article-title":"Differential regulation of fronto-executive function by the monoamines and acetylcholine","volume":"17","author":"Robbins","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib76","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/schbul\/sbi044","article-title":"Synthesizing schizophrenia: a bottom-up, symptomatic approach","volume":"31","author":"Robbins","year":"2005","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib77","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","article-title":"PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats","volume":"21","author":"Rodefer","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1162\/089892900561931","article-title":"Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans","volume":"12","author":"Rogers","year":"2000","journal-title":"J.\u00a0Cogn. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0278-2626(03)00277-X","article-title":"The functions of the orbitofrontal cortex","volume":"55","author":"Rolls","year":"2004","journal-title":"Brain Cogn."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.57.1.120","article-title":"Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type","volume":"57","author":"Sahakian","year":"1994","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib81","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00001756-200205070-00030","article-title":"Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations","volume":"13","author":"Schoenbaum","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2005.11.005","article-title":"Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats","volume":"168","author":"Schwabe","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/h0025394","article-title":"Discrimination reversal and spatial alternation associated with septal and caudate dysfunction in rats","volume":"65","author":"Schwartzbaum","year":"1968","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib85","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(02)00040-2","article-title":"Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat","volume":"134","author":"Stefani","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopsych.2004.11.031","article-title":"Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia","volume":"57","author":"Stefani","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00241119","article-title":"The nucleus accumbens in monkeys (Macaca fascicularis). III. Reversal learning","volume":"106","author":"Stern","year":"1995","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00194-1","article-title":"Ketamine impairs multiple cognitive domains in rhesus monkeys","volume":"68","author":"Taffe","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/113.3.617","article-title":"Cognitive and motor deficits in the acquisition of an object retrieval\/detour task in MPTP-treated monkeys","volume":"113","author":"Taylor","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib90","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuint.2009.10.011","article-title":"Opposite effect of phencyclidine on activity-regulated cytoskeleton-associated protein (Arc) in juvenile and adult limbic rat brain regions","volume":"56","author":"Thomsen","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib91","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.npp.1300732","article-title":"Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys","volume":"30","author":"Tsukada","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib92","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.026_bib93","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1111\/j.1460-9568.2006.04826.x","article-title":"Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task","volume":"23","author":"Walker","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib94","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.0953-816x.2001.01546.x","article-title":"Dissociable contributions of the orbitofrontal and lateral prefrontal cortex of the marmoset to performance on a detour reaching task","volume":"13","author":"Wallis","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib95","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.schres.2007.03.010","article-title":"Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction","volume":"93","author":"Waltz","year":"2007","journal-title":"Schizophr Res."},{"key":"10.1016\/j.neuropharm.2011.08.026_bib96","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1111\/j.1460-9568.2005.04143.x","article-title":"Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control","volume":"21","author":"Winstanley","year":"2005","journal-title":"Eur. J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:37:05Z","timestamp":1686271025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811003595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0028390811003595"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.026","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}